--2024/Q4-- / 8.879M--
--2024/Q3-- / 8.135M--
Aug 8, 20242024/Q26.957M / 19.162M--
May 9, 20242024/Q128.935M / 9.065M--
Feb 22, 20242023/Q4-1.917M / 11.359M--
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 19.599
- +0.089+0.46%
Trading Oct 15 12:04 ET
1.99BMarket Cap-3576P/E (TTM)
19.850High19.300Low743.40KVolume19.570Open19.510Pre Close14.58MTurnover0.74%Turnover RatioLossP/E (Static)101.58MShares34.87052wk High2.05P/B1.97BFloat Cap17.09052wk Low--Dividend TTM100.30MShs Float202.730Historical High--Div YieldTTM2.82%Amplitude9.180Historical Low19.612Avg Price1Lot Size
Intellia Therapeutics Key Stats
Intellia Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 22 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Intellia Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
